Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A summary and conclusions from the meeting.

Fiona H Marshall¹

¹Department of Pharmacology, University of Cambridge, Cambridge CB2 1QJ, UK. fhm24@cam.ac.uk

Journal of Molecular Neuroscience : MN

|July 14, 2005

Summary

The concept of seven transmembrane (7TM) receptor oligomerization is now established scientific fact, supported by diverse evidence. This shift moves the field from hypothesis to accepted understanding of receptor interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.

Cell·2021

Same author

Targeting impaired adult hippocampal neurogenesis in ageing by leveraging intrinsic mechanisms regulating Neural Stem Cell activity.

Ageing research reviews·2021

Same author

Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub> -acetylcholine receptor agonist: A randomized cross-over trial.

British journal of clinical pharmacology·2021

Same author

Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M<sub>1</sub> receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study.

Alzheimer's research & therapy·2021

Same author

First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M<sub>1</sub> -receptor partial agonist for the treatment of dementias.

British journal of clinical pharmacology·2020

Same author

Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.

Journal of medicinal chemistry·2019

Area of Science:

Biochemistry
Molecular Biology
Pharmacology

Background:

The existence of seven transmembrane (7TM) receptor oligomerization was previously debated, often considered an experimental artifact.
Early work by Agnati and Fuxe in the 1980s proposed receptor mosaics, while biochemical evidence for dimerization accumulated in the 1990s.

Purpose of the Study:

To present overwhelming evidence establishing receptor oligomerization as a scientifically accepted phenomenon.
To review the historical development and current understanding of 7TM receptor signaling and interactions.

Main Methods:

The abstract does not detail specific experimental methods but refers to a range of evidence presented at a meeting.
Evidence cited includes direct imaging, biochemical assays, cellular studies, and in vivo data from animal models and human cells.

Main Results:

A consensus was reached at the Wenner-Gren meeting, confirming receptor oligomerization as a fact, not a hypothesis.
The meeting highlighted the evolution of understanding 7TM receptor signaling beyond G proteins to include beta-arrestin and GRKs.

Conclusions:

Receptor oligomerization is now an established concept in the field of 7TM receptors.
The foundational work on receptor-receptor interactions has paved the way for current advancements in understanding receptor signaling mechanisms.

Related Experiment Videos